BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2284757)

  • 1. [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
    Ermakovich II; Ladnyĭ AI; Volkov VI; Tseluĭko VI
    Vrach Delo; 1990 Sep; (9):25-8. PubMed ID: 2284757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
    Volkov VI; Ladnyĭ AI
    Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prostacyclin-thromboxane system and thrombocytic-vascular hemostasis in patients with ischemic heart disease in the preoperative period].
    Abbakumov VV; Vinnitskiĭ LI; Kattakhanova RIu; Studennikova LN; Egorova IA; Smirnova LA
    Anesteziol Reanimatol; 1992; (1):42-4. PubMed ID: 1524251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
    Kishi Y; Numano F; Oniki T; Yajima M; Numano F
    Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of the calcium antagonist diltiazem on the prostacyclin-thromboxane ratio in the plasma of ischemic heart disease patients].
    Brovkovich VM; Topchiĭ II; Abidov AA
    Vopr Med Khim; 1991; 37(2):37-9. PubMed ID: 1897189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of physical load on the platelet function and ultrastructure in patients with ischemic heart disease.
    Oral I; Hrcková Y; Frysák Z; Kamarád V
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():39-41. PubMed ID: 1344596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombocyte function and the prostacyclin-thromboxane system in patients with acute myocardial infarct].
    Aliavi AL
    Vrach Delo; 1988 Mar; (3):42-4. PubMed ID: 3293319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostacyclin-thromboxane system in children and adolescents with a high risk of developing ischemic heart disease].
    Akimova EV
    Vopr Med Khim; 1992; 38(2):47-9. PubMed ID: 1413633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte function in physical exertion and induced myocardial ischemia in patients with ischemic heart disease].
    Shalaev SV; Panchenko EP; Karasev AV; Pisareva NA; Ovtrakht NV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):28-33. PubMed ID: 3426815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytic-vascular hemostasis at rest and under physical loading in patients with ischemic heart disease].
    Mingazetdinova LN; Shaĭmukhametova LT
    Kardiologiia; 1993; 33(3):12-4. PubMed ID: 8377329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and ischemic heart disease.
    Weiss HJ
    N Engl J Med; 1980 Jan; 302(4):225-6. PubMed ID: 7350464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
    Tashchuk VK; Savitskiĭ SIu; Shumakov VA; Popova LI; Malinovskaia IE; Reĭko MN
    Vrach Delo; 1991 Jun; (6):28-30. PubMed ID: 1832506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
    Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.